About Srinagarind Hospital
โรงพยาบาลศรีนครินทร์ เป็นโรงพยาบาลมหาวิทยาลัยระดับตติยภูมิขั้นสูงแห่งแรกในภาคตะวันออกเฉียงเหนือและเป็นโรงเรียนแพทย์สังกัดคณะแพทยศาสตร์ มหาวิทยาลัยขอนแก่น
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Khon Kaen University
18
Janssen Research & Development, LLC
5
Allergan
4
Boehringer Ingelheim
4
The HIV Netherlands Australia Thailand Research Collaboration
4
Gilead Sciences
3
Hoffmann-La Roche
3
University of Minnesota
3
Actelion
2
Merck Sharp & Dohme LLC
2
Pharmasset
2
Clinical Trials at Srinagarind Hospital
During the past decade, Srinagarind Hospital conducted 38 clinical trials. In the 10-year time frame, 38 clinical trials started and 13 clinical trials were completed, i.e. on
average, 34.2% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 6 clinical trials were completed. i.e. 37.5%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer
2003-04-18
2011-04-21
Completed
1,886
Single Dose of 1% Tropicamide and 10% Phenylephrine for Pupillary Dilation
2004-12-01
2005-06-01
Completed
80
A Prospective, Randomised, Double-blind, Double-dummy, Forced-titration, Multicentre, Parallel Group, One Year Treatment Trial to Compare Telmisartan (MICARDIS) 80 mg Versus Losartan (COZAAR) 100 mg, in Hypertensive Type 2 Diabetic Patients With Overt Nephropathy (AMADEO Study)
2003-07-01
Completed
860
Postoperative Pain Control After Kidney Surgery : a Comparison of Intrathecal Morphine Plus PCA and PCA Only
2005-01-01
2005-11-01
Unknown status
80
Antiemetic Effect of the Addition of Ondansetron to the Morphine Solution in Patient-Controlled Analgesia (PCA)
2005-01-01
Completed
160
Expanded Access of Deferasirox to Patients With Congenital Disorders of Red Blood Cells and Chronic Iron Overload
2005-10-01
2008-10-01
Completed
1,683
Quetiapine for Primary Insomnia Patients : A Randomized Controlled Trial
2006-12-01
2007-08-01
Completed
16
A Multicentre, Randomized Phase III Study of Rituximab as Maintenance Treatment Versus Observation in Patients With Aggressive B-cell Lymphoma: NHL-13
2006-01-01
2013-03-01
Completed
683
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Srinagarind Hospital" #1 sponsor was "Khon Kaen University" with 18 trials, followed by "Janssen Research & Development, LLC" with 5 trials
sponsored, "Allergan" with 4 trials sponsored, "Boehringer Ingelheim" with 4 trials sponsored and "The HIV Netherlands Australia Thailand Research Collaboration"
with 4 trials sponsored. Other sponsors include 36 different institutions and
companies that sponsored additional 37 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Srinagarind Hospital"
#1 collaborator was "Srinagarind Hospital, Khon Kaen University" with 5 trials as a collaborator, "National Institute of Allergy and Infectious Diseases (NIAID)" with 4 trials as a collaborator, "General Drugs House Co.,LTD." with 2 trials as a collaborator, "Gilead Sciences" with 2 trials as a collaborator and "Medical Research Council" with 2 trials as a collaborator. Other collaborators include 74 different institutions and companies that were
collaborators in the rest 79 trials.
Clinical Trials Conditions at Srinagarind Hospital
According to Clinical.Site data, the most researched conditions in "Srinagarind Hospital" are
"Cerebral Palsy" (4 trials), "Muscle Spasticity" (4 trials), "Pediatrics" (4 trials), "Chronic Hepatitis" (3 trials) and "HIV Infections" (3 trials). Many other conditions were trialed in "Srinagarind Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Srinagarind Hospital
Most popular intervention types in "Srinagarind Hospital" are "Drug" (59 trials), "Biological" (7 trials), "Device" (5 trials), "Other" (4 trials) and "Procedure" (3 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (13 trials), "Cisplatin" (5 trials), "Gemcitabine" (3 trials), "Pembrolizumab" (3 trials) and "Adefovir" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Srinagarind Hospital
The vast majority of trials in "Srinagarind Hospital" are
74 trials for "All" genders and 2 trials for "Female" genders.
Clinical Trials Status at Srinagarind Hospital
Currently, there are NaN active trials in "Srinagarind Hospital".
1 are not yet recruiting,
12 are recruiting,
12 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 37 completed trials in Srinagarind Hospital,
undefined suspended trials,
and 8 terminated clinical trials to date.
Out of the total trials that were conducted in Srinagarind Hospital, 3 "Phase 1"
clinical trials were conducted, 11 "Phase 2" clinical
trials and 43 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 8 trials, and there were
also 9 trials that are defined as “Not Applicable".